QIAGEN NV
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer (CEO).
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of QIA-DE would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1998) — listing | $80,491 1.9× | $114,592 1.9× |
| Year 6 (2003) | $66,445 1.9× | $94,778 1.8× |
| Year 11 (2008) | $40,606 1.4× | $58,498 1.4× |
| Year 16 (2013) | $22,473 1.1× | $32,433 1.1× |
| Year 21 (2018) | $10,573 0.8× | $15,262 0.8× |
| Year 26 (2023) | $4,085 0.8× | $5,901 0.8× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Venlo, Netherlands
Popular scenarios with QIA
For illustration only — not investment advice. Past performance is not indicative of future results.